COMPANY
GENERIC MEDICAL PARTNERS INC
GENERIC MEDICAL PARTNERS INC: marketing authorisation holder for Octreotide, Vancomycin, as stated by public registers.
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Octreotide | OCTREOTIDE ACETATE INJECTION (DIN 02509741), Approved Regulator Health Canada |
|---|---|
| Octreotide | OCTREOTIDE ACETATE INJECTION (DIN 02509768), Approved Regulator Health Canada |
| Octreotide | OCTREOTIDE ACETATE INJECTION (DIN 02509776), Approved Regulator Health Canada |
| Vancomycin | VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP (DIN 02435713), Marketed Regulator Health Canada |
| Vancomycin | VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP (DIN 02435721), Marketed Regulator Health Canada |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.